Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.38723 | 95 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.37369 | 95 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.36642 | 95 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.01635 | 93 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.34544 | 94 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.58229 | 96 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.26303 | 95 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.43307 | 95 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.24809 | 95 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.28648 | 94 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.39386 | 95 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.35604 | 95 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.32982 | 95 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.49585 | 95 |